title: [18 and one-half years' survival after cardiac graft. Clinical course and anatomical findings].
abstract: Operated upon in November, 1968, the last survivor of heart transplant recipients in those times has died on May 11, 1987, having survived 18 years and 6 months. The active life of this patient, however, was marred by episodes of graft rejection during the first post-operative years and by various incidents. It was mainly the complications of the immunosuppressive treatment that hampered his activities (osteoporosis) and provoked his death. Post-mortem examination confirmed that the heart was in good condition, found an active bronchial epithelioma and revealed iatrogenic lesions, namely adenomas, adenocarcinoma of the kidney and "regenerative" nodular hyperplasia of the liver with portal hypertension. Such lesions are observed in patients under long-term treatment with immunosuppressants. A "sleep apnoea" syndrome might have accounted for the formation of pulmonary hypertension lesions. The authors wish to pay their respects to this man who devoted himself to the service of other men.
authors.affiliation: Service de chirurgie cardiaque, CHU Timone, Marseille, France.
authors.forename: J R
authors.initials: JR
authors.lastname: Montiès
authors.forename: A
authors.initials: A
authors.lastname: Goudard
authors.forename: D
authors.initials: D
authors.lastname: Blin
authors.forename: C
authors.initials: C
authors.lastname: Avierinos
authors.forename: A
authors.initials: A
authors.lastname: Mouly
authors.forename: P
authors.initials: P
authors.lastname: Havlik
authors.forename: J P
authors.initials: JP
authors.lastname: Auffray
authors.forename: T
authors.initials: T
authors.lastname: Mesana
authors.forename: E
authors.initials: E
authors.lastname: Henry
authors.forename: R
authors.initials: R
authors.lastname: Choux
mesh_terms: D004719:Endomyocardial Fibrosis / Q000473:pathology; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation; D006801:Humans; D006965:Hyperplasia; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008099:Liver / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology; D008297:Male; D009206:Myocardium / Q000473:pathology; D007690:Polycystic Kidney Diseases / Q000473:pathology; D011183:Postoperative Complications / Q000209:etiology*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents
vernacular_title: Survie de 18 ans et demi après greffe cardiaque. Evolution clinique et constatations anatomiques.